What is Corcept Therapeutics's EV / EBITDA?

Corcept Therapeutics (CORT) reported EV / EBITDA of 77.2× in Q4 2025.

How has Corcept Therapeutics's EV / EBITDA changed year-over-year?

Corcept Therapeutics's EV / EBITDA increased by 106.0% year-over-year, from 37.4× to 77.2×.

What is the long-term trend for Corcept Therapeutics's EV / EBITDA?

Over 5 years (2020 to 2025), Corcept Therapeutics's EV / EBITDA has grown at a 27.5% compound annual growth rate (CAGR), from 22.9× to 77.2×.

Corcept Therapeutics CORT EV / EBITDA

EV / EBITDA at other companies

ExelixisEXEL

11.6×-1.3×

Regeneron PharmaceuticalsREGN

19.5×+3.6×

IncyteINCY

9×-28.2×

Jazz PharmaceuticalsJAZZ

17.6×-4.0×

Eli LillyLLY

25.9×-24.4×

Gilead SciencesGILD

17.5×-0.7×

Other financials

Income statement

See full

Revenue$164.9M+4.9%

Gross profit$162.0M+4.7%

Operating income-$49.6M-1,552%

Net income-$31.8M-255%

EPS (diluted)-$0.30-276%

Balance sheet

See full

Cash & equivalents$110.0M+21.1%

Total debt$9.6M+41.0%

Total equity$638.0M-6.6%

Total assets$814.9M-3.7%

Cash flow

See full

Operating cash flow-$16.8M-452%

CapEx$201.0K+93.3%

Free cash flow-$17.0M-464%

Valuation

See full

Market cap$8.58B-64.4%

Enterprise value$8.48B-65.0%

P/E181.2×+1.3×

P/S11.2×-24.0×

Profitability

See full

Gross margin98.3%-0.2pp

Operating margin-1.1%-17.2pp

Net margin6.2%-13.4pp

FCF margin15.6%-10.2pp

Returns & leverage

See full

Return on equity7.2%-14.6pp

Debt / equity0×0.0×

Current ratio2.9×-0.2×

Where this comes from

Calculated from Corcept Therapeutics’s reported figures.

enterprise value/ebitda=77.2×

Based on the most recent quarter.

The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corcept Therapeutics's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corcept Therapeutics's EV / EBITDA?: Corcept Therapeutics (CORT) reported EV / EBITDA of 77.2× in Q4 2025.
How has Corcept Therapeutics's EV / EBITDA changed year-over-year?: Corcept Therapeutics's EV / EBITDA increased by 106.0% year-over-year, from 37.4× to 77.2×.
What is the long-term trend for Corcept Therapeutics's EV / EBITDA?: Over 5 years (2020 to 2025), Corcept Therapeutics's EV / EBITDA has grown at a 27.5% compound annual growth rate (CAGR), from 22.9× to 77.2×.